CN103641848B - The process for purification of cefotiam hexetil hydrochloride - Google Patents

The process for purification of cefotiam hexetil hydrochloride Download PDF

Info

Publication number
CN103641848B
CN103641848B CN201310631141.9A CN201310631141A CN103641848B CN 103641848 B CN103641848 B CN 103641848B CN 201310631141 A CN201310631141 A CN 201310631141A CN 103641848 B CN103641848 B CN 103641848B
Authority
CN
China
Prior art keywords
cefotiam
sodium salt
reaction
mixed solvent
add
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201310631141.9A
Other languages
Chinese (zh)
Other versions
CN103641848A (en
Inventor
刘兆花
张立明
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SHANDONG XINQUAN PHARMACEUTICAL CO Ltd
Original Assignee
SHANDONG XINQUAN PHARMACEUTICAL CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SHANDONG XINQUAN PHARMACEUTICAL CO Ltd filed Critical SHANDONG XINQUAN PHARMACEUTICAL CO Ltd
Priority to CN201310631141.9A priority Critical patent/CN103641848B/en
Publication of CN103641848A publication Critical patent/CN103641848A/en
Application granted granted Critical
Publication of CN103641848B publication Critical patent/CN103641848B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36Methylene radicals, substituted by sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02Preparation
    • C07D501/04Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02Preparation
    • C07D501/12Separation; Purification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

The invention belongs to field of medicaments, be specifically related to a kind of process for purification of cefotiam hexetil hydrochloride.Cefotiam salt is made cefotiam sodium salt; The dimethyl formamide solution generation esterification of cefotiam sodium salt and carbonic acid 1-iodine ethyl ester cyclohexyl ester; The reaction solution obtained is added extraction agent, extraction; The organic phase obtained after extraction is added crystallization organic solvent, carries out crystallization under placing it in Ultrasonic Conditions, finally filter to obtain cefotiam hexetil hydrochloride.The present invention utilizes hyperacoustic sound wave irradiation to have strong orienting effect, has and strengthens forming the wave action needed for critical nucleus, can accelerate seeding process, generate nucleus fast; Can prevent there is coalescent situation during crystal growth, crystal particle diameter distribution uniform simultaneously.And safe and reliable, the granularity of the finished product prepared is large, and be easy to filter, quality product is high; And aftertreatment is simply easy, well can improve quality and the yield of product.

Description

The process for purification of cefotiam hexetil hydrochloride
Technical field
The invention belongs to field of medicaments, be specifically related to a kind of process for purification of cefotiam hexetil hydrochloride.
Background technology
Cefotiam hexetil (structural formula I), English name: Cefotiam Hexetil, English another name: Pansporin, CTM-HE.Itself is unstable, therefore medicinal forms is that cefotiam hexetil hydrochloride (formula II) cefotiam hexetil is as the oral antibacterial cephalosporin element of s-generation wide spectrum, itself there is no anti-microbial effect, is hydrolyzed to rapidly cefotiam (CTM) (formula II I) and is absorbed after oral at intestinal mucosa.。CTM is identical with in the past oral cynnematin with the anti-microbial activity of negative bacterium to gram-positive, and stablizes β-lactamase.This product, to the streptococcus aureus of clinical separation, coagulase negative staphylococcus, streptococcus pneumoniae, gonococcus, resistance to Ampicillin Trihydrate gonococcus (ABPC), moraxelle catarrhalis, intestinal bacteria, citric acid Pseudomonas, Providencia, micrococcus scarlatinae, streptococcus agalactiae, klebsiella pneumoniae, Proteus mirabilis, Hemophilus influenzae, all has stronger anti-microbial activity.Be used for the treatment of responsive microbial pharyngolaryngitis, acute bronchitis, tonsillitis, pneumonia, pyelonephritis, urocystitis, pouring mattress urethritis, purulence acne, erysipelas, perianal abscess, mazoitis, ocular infection, otitis media, sinusitis paranasal sinusitis etc.
In the process of producing cefotiam hexetil hydrochloride, there is the situation of crystal coalesces at present, cause the granularity of the finished product very little, during filtration, difficulty is large, is mingled with a large amount of crystalline mother solutions, have impact on the quality of product in product.
In prior art, cefotiam hexetil hydrochloride also exists the problem of crystal coalesces in process of production, to such an extent as to the granularity of product is very little, and during filtration, difficulty is large, is mingled with a large amount of crystalline mother solutions, have impact on the quality of product in product.For the deficiencies in the prior art, the present invention utilizes hyperacoustic sound wave irradiation to have strong orienting effect, has and strengthens forming the wave action needed for critical nucleus, can accelerate seeding process, generate nucleus fast; Ultrasonic wave can make the particle in medium obtain very large acceleration in liquid medium simultaneously, can produce cavatition, can prevent there is coalescent situation during crystal growth, crystal particle diameter distribution uniform.Meanwhile, under Ultrasonic Conditions, add crystallization organic solvent crystallization, when this prevent crystal growth, there is coalescent situation, crystal particle diameter distribution uniform, well can improve the quality of product.The method is safe and reliable, and the granularity of the finished product prepared is large, and be easy to filter, quality product is high; And aftertreatment is simply easy, well can improve product yield.
Compared with prior art, the present invention has the following advantages:
(1) the present invention utilizes hyperacoustic sound wave irradiation to have strong orienting effect, has and strengthens forming the wave action needed for critical nucleus, can accelerate seeding process, generate nucleus fast; Ultrasonic wave can make the particle in medium obtain very large acceleration in liquid medium simultaneously, can produce cavatition, can prevent there is coalescent situation during crystal growth, crystal particle diameter distribution uniform.
(2) under Ultrasonic Conditions, add crystallization organic solvent crystallization, when this prevent crystal growth, there is coalescent situation, crystal particle diameter distribution uniform, well can improve the quality of product.
(3) the present invention is safe and reliable, and the granularity of the finished product prepared is large, and be easy to filter, quality product is high; And aftertreatment is simply easy, well can improve quality and the yield of product.
Summary of the invention
For the deficiencies in the prior art, the object of the present invention is to provide a kind of process for purification of cefotiam hexetil hydrochloride, can prevent crystal from there is coalescent situation when growing, the method is safe and reliable, and aftertreatment is simply easy, effectively can improve the quality of product.
The process for purification of cefotiam hexetil hydrochloride of the present invention, comprises the following steps:
(1) cefotiam salt is made cefotiam sodium salt;
(2) the dimethyl formamide solution generation esterification of cefotiam sodium salt and carbonic acid 1-iodine ethyl ester cyclohexyl ester;
(3) reaction solution that step (2) obtains is added extraction agent, extraction;
(4) organic phase obtained after step (3) being extracted adds crystallization organic solvent, carries out crystallization, finally filter to obtain cefotiam hexetil hydrochloride under placing it in Ultrasonic Conditions.
Step (1) is that cefotiam salt and salt forming agent are stirred 0.5 ~ 1h under normal temperature condition, generates cefotiam sodium salt; Wherein: salt forming agent is the one in sodium carbonate, sodium bicarbonate or Sodium isooctanoate, sodium carbonate is preferably; Cefotiam salt is preferably cefotiam chloride, and the mol ratio of cefotiam salt and salt forming agent is 1:1.5 ~ 2.
The reaction equation of step (1) is:
In step (2), the compound method of the dimethyl formamide solution of carbonic acid 1-iodine ethyl ester cyclohexyl ester is: joined in dimethyl formamide by carbonic acid 1-iodine ethyl ester cyclohexyl ester, and stir; Wherein: the amount ratio of carbonic acid 1-iodine ethyl ester cyclohexyl ester and dimethyl formamide is 1 ~ 2:400 ~ 600, carbonic acid 1-iodine ethyl ester cyclohexyl ester is in mol, and dimethyl formamide is in mL.
In step (2), the temperature of reaction of esterification is-9 ~ 15 DEG C, and the reaction times is 10 ~ 20min; Wherein: the mol ratio of cefotiam sodium salt and carbonic acid 1-iodine ethyl ester cyclohexyl ester is 1:1 ~ 2.
The reaction equation of step (2) is:
Extraction agent is that one or more in acetone, ethyl acetate, methyl alcohol, methylene dichloride or ether mix with arbitrary proportion in step (3); Ethyl acetate.
In step (4), crystallization organic solvent is: massfraction is the mixed solvent of the organic reagent of HCl and 96-99.5% of 0.5 ~ 4%; Wherein: organic reagent is that one or both in acetone, ethanol, methyl alcohol or Virahol mix with arbitrary proportion, preferred acetone.The precipitation that this crystallization organic solvent contributes to cefotiam hexetil hydrochloride crystallization is added in organic phase.When adding this crystallization organic solvent, can increase the crystallisation process of product, better separate out cefotiam hexetil hydrochloride, effect is better.
Step (4) is be positioned in ultrasonic wave generation trough by the organic phase obtained after extraction, control temperature is 10 ~ 25 DEG C, add the crystallization organic solvent of 3-5 parts by volume under stirring, then open ultrasonic wave seeding, ultrasonic frequency is preferably 20KHz ~ 80KHz, seeding process is more conducive in this scope, stir again, and then add the crystallization organic solvent of 15-20 parts by volume, growing the grain, filtration, washing, suction filtration, vacuum-drying obtains cefotiam hexetil hydrochloride.
The seeding time is 30 ~ 50min, then churning time is 20 ~ 35min.Growing the grain temperature is 10 ~ 15 DEG C, and rearing crystal time is 1 ~ 2h.
Embodiment
Below in conjunction with embodiment, the present invention will be further described.
Embodiment 1
(1) in three-necked bottle, be dissolved in 600mL distilled water by 1.5mol sodium carbonate, then add 1mol cefotiam chloride, stir under normal temperature condition, reaction 1h, obtains cefotiam sodium salt.
(2) in 400mL solvent dimethylformamide, add 1mol cefotiam sodium salt obtained above and 1.5mol carbonic acid 1-iodine ethyl ester cyclohexyl ester, temperature of reaction is 10 DEG C, and reaction times 12min, under agitation uses water cooling.
(3) in the reaction solution obtained, add 1000ml ethyl acetate to extract.
(4) organic phase after step (3) being extracted moves in 5000ml three-necked bottle, be positioned in ultrasonic wave generation trough, control temperature is 15 DEG C, the mixed solvent (mixed solvent is massfraction is the HCl of 3% and the acetone of 97%) of 5 parts by volume is added under stirring, drip off and open ultrasonic wave seeding 40min, ultrasonic frequency is 60KHz, stir 25min more afterwards, then the mixed solvent (mixed solvent is massfraction is the HCl of 3% and the acetone of 97%) adding 15 parts by volume in three-necked bottle is continued, control temperature is at about 14 DEG C, after growing the grain 2h, filter, with the washing with acetone filter cake of 3 parts by volume, suction filtration, 50 DEG C of vacuum-dryings obtain cefotiam hexetil hydrochloride, HPLC detects purity 97.5%, productive rate 90%.
Embodiment 2
(1) in three-necked bottle, be dissolved in 700mL distilled water by 2mol sodium bicarbonate, then add 1mol cefotiam chloride, stir under normal temperature condition, reaction 0.5h, obtains cefotiam sodium salt.
(2) in 600mL solvent dimethylformamide, add 1mol cefotiam sodium salt obtained above and 2mol carbonic acid 1-iodine ethyl ester cyclohexyl ester, temperature of reaction is 15 DEG C, and reaction times 10min, under agitation uses water cooling.
(3) in the reaction solution obtained, add 1500ml methyl alcohol to extract.
(4) organic phase after step (3) being extracted moves in 5000ml three-necked bottle, be positioned in ultrasonic wave generation trough, control temperature is 10 DEG C, the mixed solvent (mixed solvent is massfraction is the HCl of 0.5% and the acetone of 99.5%) of 4 parts by volume is added under stirring, drip off and open ultrasonic generator seeding 50min, ultrasonic frequency is 20KHz, stir 20min more afterwards, then the mixed solvent (mixed solvent is massfraction is the HCl of 0.5% and the acetone of 99.5%) adding 20 parts by volume in three-necked bottle is continued, control temperature is at about 10 DEG C, after growing the grain 1h, filter, with the washing with acetone filter cake of 4 parts by volume, suction filtration, 50 DEG C of vacuum-dryings obtain cefotiam hexetil hydrochloride, HPLC detects purity 96.7%, productive rate 89.5%.
Embodiment 3
(1) in three-necked bottle, be dissolved in 700mL distilled water by 1.8mol Sodium isooctanoate, then add 1mol cefotiam chloride, stir under normal temperature condition, reaction 0.8h, obtains cefotiam sodium salt.
(2) in 500mL solvent dimethylformamide, add 1mol cefotiam sodium salt obtained above and 1.2mol carbonic acid 1-iodine ethyl ester cyclohexyl ester, temperature of reaction is-9 DEG C, and reaction times 20min, under agitation uses water cooling.
(3) in the reaction solution obtained, add 1200ml methylene dichloride to extract.
(4) organic phase after step (3) being extracted moves in 5000ml three-necked bottle, be positioned in ultrasonic wave generation trough, control temperature is 25 DEG C, the mixed solvent (mixed solvent is massfraction is the HCl of 4% and the methyl alcohol of 96%) of 3 parts by volume is added under stirring, drip off and open ultrasonic generator seeding 30min, ultrasonic frequency is 80KHz, stir 35min more afterwards, then the mixed solvent (mixed solvent is massfraction is the HCl of 4% and the methyl alcohol of 96%) adding 18 parts by volume in three-necked bottle is continued, control temperature is at about 15 DEG C, after growing the grain 1h, filter, with the methanol wash filter cake of 3 parts by volume, suction filtration, 40 DEG C of vacuum-dryings obtain cefotiam hexetil hydrochloride, HPLC detects purity 96.3%, productive rate 87.9%.
Embodiment 4
(1) in three-necked bottle, be dissolved in 800mL distilled water by 2mol sodium carbonate, then add 1mol cefotiam chloride, stir under normal temperature condition, reaction 1h, obtains cefotiam sodium salt.
(2) in 500mL solvent dimethylformamide, add 1mol cefotiam sodium salt obtained above and 1mol carbonic acid 1-iodine ethyl ester cyclohexyl ester, temperature of reaction is 0 DEG C, and reaction times 18min, under agitation uses water cooling.
(3) in the reaction solution obtained, add 1000ml ethyl acetate to extract.
(4) organic phase after step (3) being extracted moves in 5000ml three-necked bottle, be positioned in ultrasonic wave generation trough, control temperature is 15 DEG C, the mixed solvent (mixed solvent is massfraction is the HCl of 2% and the ethanol of 98%) of 4 parts by volume is added under stirring, drip off and open ultrasonic generator seeding 40min, ultrasonic frequency is 50KHz, stir 25min more afterwards, then the mixed solvent (mixed solvent is massfraction is the HCl of 2% and the ethanol of 98%) adding 16 parts by volume in three-necked bottle is continued, control temperature is at about 14 DEG C, after growing the grain 1.5h, filter, with the washing with alcohol filter cake of 3 parts by volume, suction filtration, 50 DEG C of vacuum-dryings obtain cefotiam hexetil hydrochloride, HPLC detects purity 97.2%, productive rate 86%.

Claims (1)

1. a process for purification for cefotiam hexetil hydrochloride, is characterized in that:
(1) in three-necked bottle, be dissolved in 600mL distilled water by 1.5mol sodium carbonate, then add 1mol cefotiam chloride, stir under normal temperature condition, reaction 1h, obtains cefotiam sodium salt;
(2) in 400mL solvent dimethylformamide, add 1mol cefotiam sodium salt obtained above and 1.5mol carbonic acid 1-iodine ethyl ester cyclohexyl ester, temperature of reaction is 10 DEG C, and reaction times 12min, under agitation uses water cooling;
(3) in the reaction solution obtained, add 1000ml ethyl acetate to extract;
(4) organic phase after step (3) being extracted moves in 5000ml three-necked bottle, be positioned in ultrasonic wave generation trough, control temperature is 15 DEG C, the mixed solvent of 5 parts by volume is added under stirring, drip off and open ultrasonic wave seeding 40min, ultrasonic frequency is 60KHz, stir 25min more afterwards, then continue to add the mixed solvent of 15 parts by volume in three-necked bottle, control temperature at 14 DEG C, after growing the grain 2h, filter, with the washing with acetone filter cake of 3 parts by volume, suction filtration, 50 DEG C of vacuum-dryings obtain cefotiam hexetil hydrochloride;
In step (4), mixed solvent is massfraction is the HCl of 3% and the acetone of 97%.
CN201310631141.9A 2013-11-28 2013-11-28 The process for purification of cefotiam hexetil hydrochloride Active CN103641848B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310631141.9A CN103641848B (en) 2013-11-28 2013-11-28 The process for purification of cefotiam hexetil hydrochloride

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310631141.9A CN103641848B (en) 2013-11-28 2013-11-28 The process for purification of cefotiam hexetil hydrochloride

Publications (2)

Publication Number Publication Date
CN103641848A CN103641848A (en) 2014-03-19
CN103641848B true CN103641848B (en) 2015-08-19

Family

ID=50247161

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310631141.9A Active CN103641848B (en) 2013-11-28 2013-11-28 The process for purification of cefotiam hexetil hydrochloride

Country Status (1)

Country Link
CN (1) CN103641848B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106749334A (en) * 2016-11-23 2017-05-31 扬子江药业集团北京海燕药业有限公司 A kind of preparation method of high-purity cefotiam hexetil dihydrochloride

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101619069A (en) * 2009-07-28 2010-01-06 余小强 Preparation method of cefotiam hexetil hydrochloride
CN101863907A (en) * 2010-07-07 2010-10-20 福建省福抗药业股份有限公司 Method for crystallizing cefoperazone sodium
CN101955493A (en) * 2010-08-03 2011-01-26 宁宗超 Method for preparing cefotiam hexetil hydrochloride and composition of cefotiam hexetil hydrochloride
CN102675343A (en) * 2011-03-15 2012-09-19 陈婧 Method for preparing cefotiam hexetil hydrochloride by cefotiam hydrochloride
CN102775426A (en) * 2012-08-10 2012-11-14 天津新丰制药有限公司 Crystallization method of ceftezole sodium
CN103030650A (en) * 2012-11-23 2013-04-10 深圳华润九新药业有限公司 Method for preparing cefotiam hexetil and method for preparing cefotiam hexetil dihydrochloride

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101619069A (en) * 2009-07-28 2010-01-06 余小强 Preparation method of cefotiam hexetil hydrochloride
CN101863907A (en) * 2010-07-07 2010-10-20 福建省福抗药业股份有限公司 Method for crystallizing cefoperazone sodium
CN101955493A (en) * 2010-08-03 2011-01-26 宁宗超 Method for preparing cefotiam hexetil hydrochloride and composition of cefotiam hexetil hydrochloride
CN102675343A (en) * 2011-03-15 2012-09-19 陈婧 Method for preparing cefotiam hexetil hydrochloride by cefotiam hydrochloride
CN102775426A (en) * 2012-08-10 2012-11-14 天津新丰制药有限公司 Crystallization method of ceftezole sodium
CN103030650A (en) * 2012-11-23 2013-04-10 深圳华润九新药业有限公司 Method for preparing cefotiam hexetil and method for preparing cefotiam hexetil dihydrochloride

Also Published As

Publication number Publication date
CN103641848A (en) 2014-03-19

Similar Documents

Publication Publication Date Title
CN103435632B (en) A kind of preparation method of cefuroxime axetil
CN102617606B (en) Method for preparing ceftezole sodium compound
CN101584671B (en) Cefazedone sodium medicament powder injection and method for synthesizing raw medicine of Cefazedone sodium
CN105175432B (en) Preparation method of cefditore
CN103467495A (en) Method for preparing cefixime compound
CN101486719A (en) Method for converting cefotaxime acid into sodium salt crystal
CN105541870A (en) Preparation method of cefazolin sodium with previous research quality and medicine preparation of cefazolin sodium
CN101941969A (en) Preparation method of moxifloxacin hydrochloride
CN103641848B (en) The process for purification of cefotiam hexetil hydrochloride
CN102516261A (en) Preparation method of cefdinir
CN102924482B (en) Preparation method for cefazedone sodium with low water content
CN103992337B (en) A kind of method preparing Aspoxicillin sodium easily
CN106008554A (en) Preparation method and product of ceftriaxone sodium sterile powder
CN104072518A (en) Preparation method of cefcapene diisopropylamine salt
CN107903294A (en) A kind of method of Tylosin Tartrate recrystallization
CN101550146A (en) Cefetamet pivoxil hydrochloride compound and preparation method thereof
CN102432645A (en) Method for purifying etimicin sulfate
CN104402904B (en) A kind of preparation method of flucloxacillin sodium
CN103755726A (en) Cefalonium refinement purification method
CN104151275B (en) The preparation method of Andrographolide compound
CN104230955B (en) A kind of preparation method to the acid of hydroxyl penicillin V and salt thereof
WO2014094659A1 (en) Process for preparation of meropenem trihydrate crystals
CN105385746A (en) Method for synthesizing cefoxitin acid
CN101863906B (en) Crystallization method of cefcapene ester hydrochloride monohydrate
CN105254650A (en) Synthesis method of antibacterial drug cefoxitin

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
PE01 Entry into force of the registration of the contract for pledge of patent right
PE01 Entry into force of the registration of the contract for pledge of patent right

Denomination of invention: Refining method of cefotiam axetil hydrochloride

Effective date of registration: 20211216

Granted publication date: 20150819

Pledgee: Commercial Bank of China Yiyuan branch of Limited by Share Ltd.

Pledgor: SHANDONG XINQUAN PHARMACEUTICAL Co.,Ltd.

Registration number: Y2021980015208

PC01 Cancellation of the registration of the contract for pledge of patent right
PC01 Cancellation of the registration of the contract for pledge of patent right

Date of cancellation: 20220721

Granted publication date: 20150819

Pledgee: Commercial Bank of China Yiyuan branch of Limited by Share Ltd.

Pledgor: SHANDONG XINQUAN PHARMACEUTICAL Co.,Ltd.

Registration number: Y2021980015208